国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Business / Economy

Getting medicine right for long-term growth

By Wang Wen (China Daily) Updated: 2015-02-10 07:52

Getting medicine right for long-term growth

Man buys medicine with the help of a pharmacy sales person in Chongqing municipality, Southwest China, July 21, 2014. [Photo/IC]

Export tax rebates will sharpen competitive advantage of health product companies in overseas markets.

The recent export tax rebate adjustments announced by the government will buoy the fortunes of Chinese medical product exporters and sharpen their competitive edge, industry experts said on Monday.

The Ministry of Finance last year announced adjustments in the export rebate rates for some goods, including 67 medicines and health products. Tax rebates for 55 Western medicines, four traditional Chinese medicines and eight medical devices have been revised upwards to between 2 and 13 percent, depending on the type of product.

About 6,100 companies from China are set to benefit from the new regulations, with the total value of their exports and imports being about $9.426 billion during the first 11 months of 2014, according to statistics provided by the China Chamber of Commerce for Import and Export of Medicines and Health Products.

Meng Dongping, vice-chairwoman of the chamber, said the tax rebates have come at an opportune time for the medical products industry, as it has been seeing slower growth rates in the past years. Medical product exports fell from a relatively high growth rate of 20 percent in 2012 to about 7 percent last year.

Breaking down the numbers further, Deng said the expected total volume of China's medicine exports and imports for 2014 would be about $100 billion and that there has been a slowdown in exports. The chamber estimates that exports will remain relatively subdued this year, while the global market growth rate would be around 4 to 7 percent.

According to Meng, the rapidly shrinking global market, rising costs and currency appreciation pressures are hurting exports.

In addition, domestic factors like higher human resource costs, raw materials, energy and environmental protection costs are fast eroding the price advantage of Chinese companies.

"The higher export rebates will help companies recoup some of the additional costs and also enhance the competitive advantage to some extent." The measures are especially beneficial for the biomedicine industry, she said.

"The adjustments mainly focus on the products with high added value and high technology, which means the government will encourage enterprises to develop such products," Meng said.

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
那曲县| 郑州市| 苗栗县| 东辽县| 衡水市| 巴青县| 肥城市| 出国| 双柏县| 云霄县| 屯留县| 华坪县| 蕲春县| 房产| 东源县| 乌拉特中旗| 谷城县| 安泽县| 北碚区| 满城县| 桃江县| 喀什市| 绩溪县| 天峨县| 收藏| 长垣县| 留坝县| 佳木斯市| 黑水县| 宣武区| 临海市| 五华县| 两当县| 洪洞县| 建阳市| 平江县| 余庆县| 白银市| 桦甸市| 扬州市| 内乡县|